Pegylated IFN-α 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B

AIM: To investigate the role of pegylated-interferon (IFN) α-2b in the management of patients with lamivudine-resistant chronic hepatitis B. METHODS: Twenty consecutive anti-HBe positive patients were treated with pegylated IFN α-2b (100 μg sc once weekly) for 12 mo. There was no interruption in lam...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vassiliadis, Themistoklis, Patsiaoura, Kalliopi, Tziomalos, Konstantinos, Gkiourtzis, Theodoros, Giouleme, Olga, Grammatikos, Nikolaos, Rizopoulou, Despoina, Nikolaidis, Nikolaos, Katsinelos, Panagiotis, Orfanou-Koumerkeridou, Eleni, Eugenidis, Nikolaos
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Co., Limited 2006
Teme:
Rapid Communication
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4088081/
https://ncbi.nlm.nih.gov/pubmed/16688836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i15.2417
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items